CS205041B2 - Process for preparing 2-hydroxymethyl-3-hydroxy-6-/1-hydroxy-2-terc.butylaminomethyl/pyridine - Google Patents

Process for preparing 2-hydroxymethyl-3-hydroxy-6-/1-hydroxy-2-terc.butylaminomethyl/pyridine Download PDF

Info

Publication number
CS205041B2
CS205041B2 CS765863A CS586376A CS205041B2 CS 205041 B2 CS205041 B2 CS 205041B2 CS 765863 A CS765863 A CS 765863A CS 586376 A CS586376 A CS 586376A CS 205041 B2 CS205041 B2 CS 205041B2
Authority
CS
Czechoslovakia
Prior art keywords
hydroxy
hydroxymethyl
formula
pyridine
maleate
Prior art date
Application number
CS765863A
Other languages
Czech (cs)
English (en)
Inventor
Ronnie D Carroll
James R Tretter
Bernard S Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS205041B2 publication Critical patent/CS205041B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS765863A 1975-10-03 1976-09-09 Process for preparing 2-hydroxymethyl-3-hydroxy-6-/1-hydroxy-2-terc.butylaminomethyl/pyridine CS205041B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/619,302 US4011231A (en) 1975-10-03 1975-10-03 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate

Publications (1)

Publication Number Publication Date
CS205041B2 true CS205041B2 (en) 1981-04-30

Family

ID=24481329

Family Applications (2)

Application Number Title Priority Date Filing Date
CS765863A CS205041B2 (en) 1975-10-03 1976-09-09 Process for preparing 2-hydroxymethyl-3-hydroxy-6-/1-hydroxy-2-terc.butylaminomethyl/pyridine
CS765863A CS205042B2 (en) 1975-10-03 1976-09-09 Method of producing salt of 2-phenyl-6-/1-hydroxy-2-tertiary butyl-amino-ethyl/-4h-pyrido/3,2-d/-1,3-dioxine with maleic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS765863A CS205042B2 (en) 1975-10-03 1976-09-09 Method of producing salt of 2-phenyl-6-/1-hydroxy-2-tertiary butyl-amino-ethyl/-4h-pyrido/3,2-d/-1,3-dioxine with maleic acid

Country Status (30)

Country Link
US (1) US4011231A (el)
JP (1) JPS5246081A (el)
AR (1) AR213180A1 (el)
AT (1) AT353789B (el)
BE (1) BE846471A (el)
BG (1) BG27544A3 (el)
CA (1) CA1059518A (el)
CH (1) CH616424A5 (el)
CS (2) CS205041B2 (el)
DD (2) DD133672A5 (el)
DE (1) DE2640123C3 (el)
DK (1) DK147049C (el)
ES (2) ES451746A1 (el)
FI (1) FI64354C (el)
FR (1) FR2326191A1 (el)
GB (1) GB1510075A (el)
GR (1) GR61628B (el)
HU (2) HU177493B (el)
IE (1) IE43503B1 (el)
LU (1) LU75898A1 (el)
NL (1) NL164274C (el)
NO (1) NO147027C (el)
PH (1) PH14511A (el)
PL (1) PL106863B1 (el)
PT (1) PT65619B (el)
RO (1) RO69886A (el)
SE (2) SE428127B (el)
SU (2) SU673168A3 (el)
YU (1) YU39545B (el)
ZA (1) ZA765253B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477671A (en) * 1981-02-09 1984-10-16 Pfizer Inc. 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
US5395939A (en) * 1993-11-30 1995-03-07 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250778A (en) * 1962-11-29 1966-05-10 Hoffmann La Roche Intermediates for and synthesis of vitamin b and related compounds
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines

Also Published As

Publication number Publication date
AU1788376A (en) 1978-03-16
GB1510075A (en) 1978-05-10
BE846471A (fr) 1977-03-23
NO147027B (no) 1982-10-11
SU725562A3 (ru) 1980-03-30
IE43503L (en) 1977-04-03
HU172998B (hu) 1979-01-28
BG27544A3 (en) 1979-11-12
JPS5246081A (en) 1977-04-12
PH14511A (en) 1981-08-24
NL7610683A (nl) 1977-04-05
ES451746A1 (es) 1977-08-16
FR2326191B1 (el) 1978-11-17
FI64354B (fi) 1983-07-29
ZA765253B (en) 1977-08-31
DE2640123C3 (de) 1980-09-25
PL106863B1 (pl) 1980-01-31
LU75898A1 (el) 1977-05-11
FR2326191A1 (fr) 1977-04-29
PT65619A (en) 1976-10-01
DE2640123A1 (de) 1977-04-07
SE7609497L (sv) 1977-04-04
CA1059518A (en) 1979-07-31
JPS5519210B2 (el) 1980-05-24
CS205042B2 (en) 1981-04-30
SE8003311L (sv) 1980-04-30
DK147049C (da) 1984-10-01
DK147049B (da) 1984-03-26
FI64354C (fi) 1983-11-10
YU39545B (en) 1984-12-31
NO763307L (el) 1977-04-05
ES457257A1 (es) 1978-02-01
DD133672A5 (de) 1979-01-17
DE2640123B2 (de) 1980-01-31
SU673168A3 (ru) 1979-07-05
NL164274C (nl) 1980-12-15
IE43503B1 (en) 1981-03-11
HU177493B (en) 1981-10-28
RO69886A (ro) 1981-09-24
FI762693A (el) 1977-04-04
YU216576A (en) 1982-06-30
DK434176A (da) 1977-04-04
SE437159B (sv) 1985-02-11
PT65619B (en) 1978-04-05
GR61628B (en) 1978-12-04
AR213180A1 (es) 1978-12-29
ATA692376A (de) 1979-05-15
SE428127B (sv) 1983-06-06
AT353789B (de) 1979-12-10
NO147027C (no) 1983-01-19
DD129325A5 (de) 1978-01-11
CH616424A5 (el) 1980-03-31
NL164274B (nl) 1980-07-15
US4011231A (en) 1977-03-08

Similar Documents

Publication Publication Date Title
EP0161534B1 (en) New process for the synthesis of pyrido-imidazo-refamycins
HU189738B (en) Process for preparing intermediary compounds of omeprazole
US5239077A (en) Highly pure amidoximes
DK160829B (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
CS205041B2 (en) Process for preparing 2-hydroxymethyl-3-hydroxy-6-/1-hydroxy-2-terc.butylaminomethyl/pyridine
AU773698B2 (en) Intermediates for the production of quinolone carboxylic acid derivatives
GB2056437A (en) Secoergoline derivatives
EP0064317A2 (en) Pyrrolo(2,3-d)carbazole derivatives, preparation thereof and their therapeutical use
IL116384A (en) Iliden assemblies and their preparation
TW414791B (en) Process and intermediates for preparing naphthyridonecarboxylic acid salts
US6545149B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
US4031108A (en) 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
JP4138883B2 (ja) アクリドン誘導体及び8―ヒドロキシイミダゾアクリジノン誘導体の製造方法
GB2101990A (en) Isocarbostyril derivatives
KR800000904B1 (ko) 2-하이드록시메틸-3-하이드록시-6-(1-하이드록시-2-3급-부틸아미노에틸)피리딘의 제법
JPH04169583A (ja) フェノチアジン誘導体およびその製造方法
US4709026A (en) Ketosultams
US20030135043A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
CN118324683A (zh) 一种3-氯-2-氧代-[1,3']双吡咯烷基-1'-羧酸烯丙基酯的制备方法
US5905154A (en) Process for the preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds
Barrett et al. Alkylation of 1-(N-(Hydroxymethyl)-N-methylamino)-4-quinolones. An Improved Preparation of Intermediates for Novel Potent Tricyclic Quinolone Antibacterial Agents.
JP3127505B2 (ja) ピラゾロピリジン誘導体の製造法
JPH06228103A (ja) 新規なオクタヒドロアクリジン誘導体とその製造方法
CA2404455A1 (en) Imidazopyridin-8-ones
HU191693B (en) Process for production of derivatives of 9-or-11 substituated apovincamin acid